Clinical Trials
53 trialsSafety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC
Amgen
GINAKIT2
Baylor College of Medicine
CareRA2020
Universitaire Ziekenhuizen KU Leuven
E/M
Nova Southeastern University
Advanced Therapeutics in Rheumatoid Arthritis (RA)
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
STARA
Georgetown University
Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet
University of California, Irvine
Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis
The Cleveland Clinic
Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells
Chinese PLA General Hospital
BMTCTN0403
National Heart, Lung, and Blood Institute (NHLBI)
Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
National Institute of Allergy and Infectious Diseases (NIAID)
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Pfizer
Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression
University of Illinois at Chicago
Treatment of Axial Spondyloarthritis by Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ IgG Fc Fusion Protein
Sun Yat-sen University
Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA)
Amgen
A Pilot Study to Examine the Feasibility and Effect of Tumor Necrosis Factor (TNF) Inhibition on HIV Disease
University of Wisconsin, Madison
A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Pfizer
Can We Miss Pigmented Lesions in Psoriasis Patients?
University of Alabama at Birmingham
Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal Injury
National Institutes of Health Clinical Center (CC)
Phase I & Biological Study of Etanercept & Weekly Docetaxel in Patients With Advanced Solid Tumors
Ohio State University Comprehensive Cancer Center
Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic Adenocarcinoma
Ohio State University Comprehensive Cancer Center
Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic Syndrome
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant
Children's Oncology Group
Study of TNFR:Fc (Enbrel) in the Treatment of Asthma
National Institutes of Health Clinical Center (CC)
REFINE
Amgen
Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical Trials
Amgen
Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Ohio State University Comprehensive Cancer Center
Etanercept in Rheumatoid Arthritis and Vascular Inflammation
Innovaderm Research Inc.
SWITCH
University of Leeds
Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World"
Central South University
Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant
University of Michigan Rogel Cancer Center
Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome
Haukeland University Hospital
Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis
Chung Shan Medical University
Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation
FDA Office of Orphan Products Development
Human Tumor Necrosis Factor Alpha (TNFa)-Induced Pre-B Cell Bone Marrow Emigrants
University of Pittsburgh
Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis
Amgen
Evaluating the Safety of Etanercept in the Treatment of Psoriasis in Adult Subjects
Amgen
Etanercept for the Treatment of Lupus Nephritis
National Institute of Allergy and Infectious Diseases (NIAID)
Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia
M.D. Anderson Cancer Center
Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia
The University of Texas Health Science Center at San Antonio
Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes
Fred Hutchinson Cancer Center
A Pilot Study of Etanercept in Dermatomyositis
Brigham and Women's Hospital
Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer
Mayo Clinic
Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes
Fred Hutchinson Cancer Center
Biological Therapy in Treating Patients With Myelodysplastic Syndrome
Fred Hutchinson Cancer Center
Study Evaluating Etanercept in Moderate to Severe Asthma
Wyeth is now a wholly owned subsidiary of Pfizer
Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis
Chinese University of Hong Kong
TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis
National Institutes of Health Clinical Center (CC)
Etanercept to Treat Wegener's Granulomatosis
National Institutes of Health Clinical Center (CC)
Study of Etanercept and Celecoxib to Treat Temporomandibular Disorders (Painful Joint Conditions)
National Institutes of Health Clinical Center (CC)